Avectas is a cell engineering technology company, enabling the manufacture of cell therapies. The Company's technology, Solupore, delivers advanced molecules such as mRNA, proteins and gene editing tools to a range of primary cell types including T-cells for immuno-oncology and gene editing applications. Avectas's approach makes cells extracted from a patient temporarily permeable, allowing for the introduction of edited DNA material.
|Employees (est.) (Apr 2020)||29|
Avectas total Funding
Avectas latest funding size
Time since last funding
|a year ago|
|Horizon 2020, EASME - EU Executive Agency for SMEs, Seamus Mulligan|
Avectas has 288 Twitter Followers. The number of followers has increased 1.7% month over month and increased 9% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Avectas founded?
Avectas was founded in 2010.
Who are Avectas key executives?
Avectas's key executives are Michael Maguire, Shirley O'Dea and Ann Brady.
How many employees does Avectas have?
Avectas has 29 employees.
Who are Avectas competitors?
Competitors of Avectas include NeoTherma Oncology, Xoft and ScreenCell.
Where is Avectas headquarters?
Avectas headquarters is located at Eolas building, Maynooth University, Maynooth, Kildare.
Where are Avectas offices?
Avectas has offices in Kildare and Cambridge.
How many offices does Avectas have?
Avectas has 2 offices.
Receive alerts for 300+ data fields across thousands of companies